{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:05:54Z","timestamp":1790654754485,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.neulet.2019.05.029","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T11:51:11Z","timestamp":1558007471000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia"],"prefix":"10.1016","volume":"706","author":[{"given":"Samaneh","family":"Ghotbi Ravandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-5849","authenticated-orcid":false,"given":"Mohammad","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamideh","family":"Bashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monavvar","family":"Saeedi Goraghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Khodamoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1543-6240","authenticated-orcid":false,"given":"Masoumeh","family":"Nozari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2019.05.029_bib0005","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1211\/jpp.61.07.0001","article-title":"Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research","volume":"61","author":"Ye","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neulet.2019.05.029_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013489","article-title":"Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL\/6 mice","volume":"5","author":"Ma","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2019.05.029_bib0015","first-page":"1145","article-title":"Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat, Iran","volume":"14","author":"Negahdar","year":"2015","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.neulet.2019.05.029_bib0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1248\/bpb.29.623","article-title":"Berberry extract reduces neuronal damage and N-Methyl-D-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia","volume":"29","author":"Yoo","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neulet.2019.05.029_bib0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neulet.2008.09.064","article-title":"Neuroprotective effects of berberine on stroke models in vitro and in vivo","volume":"447","author":"Zhou","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.05.029_bib0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/19768354.2008.9647174","article-title":"Neuroprotective effects of berberine in neurodegeneration model rats induced by ibotenic acid","volume":"12","author":"Lim","year":"2008","journal-title":"Animal Cells Syst. (Seoul)"},{"key":"10.1016\/j.neulet.2019.05.029_bib0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4306\/pi.2013.10.4.417","article-title":"Beneficial effects of sigma-1 agonist fluvoxamine for tardive dyskinesia and tardive akathisia in patients with schizophrenia: report of tree cases","volume":"10","author":"Albayrak","year":"2013","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.neulet.2019.05.029_bib0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5607\/en.2010.19.3.140","article-title":"Effect of berberine on cell survival in the developing rat brain damaged by MK-801","volume":"19","author":"Lee","year":"2010","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.neulet.2019.05.029_bib0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0168-0102(03)00197-4","article-title":"Dose-dependent effect of MK-801 on the levels of neuropeptides processing enzymes in rat brain regions","volume":"47","author":"Ahmed","year":"2003","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neulet.2019.05.029_bib0050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.pnpbp.2005.03.004","article-title":"(+)-MK-801 induced social withdrawal in rats; A model for negative symptoms of schizophrenia","volume":"29","author":"Rung","year":"2005","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry."},{"key":"10.1016\/j.neulet.2019.05.029_bib0055","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbr.2011.10.052","article-title":"Consequences of early life MK-801 administration: long-term behavioural effects and relevance to schizophrenia research","volume":"227","author":"Lim","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2019.05.029_bib0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10673229609017192","article-title":"The glutamatergic dysfunction hypothesis for schizophrenia","volume":"3","author":"Coyle","year":"1996","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.neulet.2019.05.029_bib0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0165-1781(95)02698-V","article-title":"Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs","volume":"58","author":"Maes","year":"1995","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2019.05.029_bib0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fitote.2015.04.004","article-title":"Isoquinoline alkaloids as prolyl oligopeptidase inhibitors","volume":"103","author":"Cahl\u00edkov\u00e1","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.neulet.2019.05.029_bib0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.lfs.2015.07.003","article-title":"Prolyl endopeptidase and dipeptidyl peptidase IV are associated with externalizing and aggressive behaviors in normal and autistic adolescents","volume":"136","author":"Frenssen","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.neulet.2019.05.029_bib0080","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cmdc.200600303","article-title":"The natural product berberine is a human prolyl oligopeptidase inhibitor","volume":"2","author":"Tarrago","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.neulet.2019.05.029_bib0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2015.01.078","article-title":"The therapeutic potential of Berberine chloride hydrate against harmaline-induced motor impairments in a rat model of tremor","volume":"590","author":"Vaziri","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.05.029_bib0090","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1007\/s00213-014-3580-8","article-title":"Enriched environment prevents cognitive and motor deficits associated with postnatal MK-801 treatment","volume":"231","author":"Nozari","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2019.05.029_bib0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0091-3057(77)90036-3","article-title":"A new device for the rapid measurement of impaired motor function in mice","volume":"6","author":"Coughenour","year":"1977","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2019.05.029_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2019.02.026","article-title":"Behavioral consequences of simultaneous postnatal exposure to MK-801 and static magnetic field in male wistar rats","volume":"701","author":"Saeedi Goraghani","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.05.029_bib0105","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.biopha.2016.12.116","article-title":"The effect of Elettaria cardamomum extract on anxiety-like behavior in a rat model of post-traumatic stress disorder","volume":"87","author":"Masoumi-Ardakani","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neulet.2019.05.029_bib0110","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neulet.2019.05.029_bib0115","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1097\/00001756-200011090-00013","article-title":"Mice are not little rats: species differences in a one-day water maze task","volume":"11","author":"Frick","year":"2000","journal-title":"Neuroreport."},{"key":"10.1016\/j.neulet.2019.05.029_bib0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev.neuro.27.070203.144327","article-title":"Critical period regulation","volume":"27","author":"Hensch","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2019.05.029_bib0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/syn.21734","article-title":"Neonatal exposure to MK-801 reduces mRNA expression of mGlu3 receptors in the medial prefrontal cortex of adolescent rats","volume":"68","author":"Uehara","year":"2014","journal-title":"Synapse"},{"key":"10.1016\/j.neulet.2019.05.029_bib0130","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.0805854106","article-title":"MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction","volume":"106","author":"Kocerha","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2019.05.029_bib0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrn2153","article-title":"NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders","volume":"8","author":"Lau","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2019.05.029_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","article-title":"Glutamate receptor function in learning and memory","volume":"140","author":"Riedel","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2019.05.029_bib0145","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81972-8","article-title":"Mice with reduced NMDA receptor expression display behaviors related to schizophrenia","volume":"98","author":"Mohn","year":"1999","journal-title":"Cell."},{"key":"10.1016\/j.neulet.2019.05.029_bib0150","article-title":"NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update","author":"Cadinu","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2019.05.029_bib0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coph.2004.08.008","article-title":"PCP: from pharmacology to modelling schizophrenia","volume":"5","author":"Morris","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neulet.2019.05.029_bib0160","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/FBP.0000000000000003","article-title":"MK-801-induced and scopolamine-induced hyperactivity in rats neonatally treated chronically with MK-801","volume":"24","author":"Furuie","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neulet.2019.05.029_bib0165","first-page":"712","article-title":"Concentration change of DA, DOPAC, Glu and GABA in brain tissues in schizophrenia developmental model rats induced by MK-801","volume":"36","author":"Liu","year":"2011","journal-title":"Zhong Nan Da Xue Xue Bao. Yi Xue Ban."},{"key":"10.1016\/j.neulet.2019.05.029_bib0170","article-title":"Postnatal BDNF expression profiles in prefrontal cortex and hippocampus of a rat schizophrenia model induced by MK-801 administration","volume":"2010","author":"Si","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.neulet.2019.05.029_bib0175","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jpsychires.2012.01.022","article-title":"T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal period","volume":"46","author":"Uehara","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2019.05.029_bib0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/026988119500900102","article-title":"Behavioural interaction between the NMDA antagonist MK-801 and the dopaminergic antagonist haloperidol: support for a balance model","volume":"9","author":"Dai","year":"1995","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neulet.2019.05.029_bib0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0006-8993(92)91091-R","article-title":"Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons","volume":"590","author":"Zhang","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2019.05.029_bib0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuro.2016.10.008","article-title":"Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer\u2019s-like dementia: involvement of acetylcholinesterase and cell death","volume":"57","author":"de Oliveira","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neulet.2019.05.029_bib0195","first-page":"53","article-title":"Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia","volume":"21","author":"Aski","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.neulet.2019.05.029_bib0200","first-page":"1129","article-title":"Neuroprotective effect of berberine against learning and memory deficits in diffuse axonal injury, Exp. Ther. Med. Hong-Cai Al. 2018. \u201cNeuroprotective Eff. Berberine against Learn","volume":"15","author":"Wang","year":"2018","journal-title":"Mem. Deficits Diffus. Axonal Inj. Exp. Ther. Med."},{"key":"10.1016\/j.neulet.2019.05.029_bib0205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.brainres.2014.02.021","article-title":"Berberine was neuroprotective against an in vitro model of brain ischemia: survival and apoptosis pathways involved","volume":"1557","author":"Sim\u00f5es Pires","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2019.05.029_bib0210","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.fct.2017.11.025","article-title":"Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer\u2019s-like disease in rats","volume":"111","author":"Hussien","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neulet.2019.05.029_bib0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pbb.2015.07.001","article-title":"Protective effect of berberine, an isoquinoline alkaloid ameliorates ethanol-induced oxidative stress and memory dysfunction in rats","volume":"136","author":"Patil","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2019.05.029_bib0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2012.03.065","article-title":"Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-\u03baB expression, ameliorated BBB permeability","volume":"1459","author":"Zhang","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2019.05.029_bib0225","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3892\/ijmm.2014.1656","article-title":"Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson\u2019s disease","volume":"33","author":"KIM","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neulet.2019.05.029_bib0230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5114\/aoms.2013.33354","article-title":"Effects of berberine on \u03b2-secretase activity in a rabbit model of Alzheimer\u2019s disease","volume":"9","author":"Panahi","year":"2013","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.neulet.2019.05.029_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107129","article-title":"Mitochondria and NMDA receptor-dependent toxicity of berberine sensitizes neurons to glutamate and rotenone injury","volume":"9","author":"Kysenius","year":"2014","journal-title":"PLoS One"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019303477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019303477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T16:08:45Z","timestamp":1559750925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019303477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":47,"alternative-id":["S0304394019303477"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.05.029","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}